← back to search

Christian Fottner

Johannes Gutenberg University Mainz · DE
Area of research
Epidemiology · Oncology
Research interest
Research interests include Neuroendocrine Tumor Research Advances, Lung Cancer Research Studies, Adrenal and Paraganglionic Tumors, and Neuroblastoma Research and Treatments.
h-index
29
citations
3,304
works
148
NIH funding
primary concept
email

Recent publications

Combined [18F]Fluorodeoxyglucose PET and [123I]Iodometomidate-SPECT for diagnostic evaluation of indeterminate adrenal neoplasias—the cross-sectional diagnostic test accuracy study FAMIAN
EBioMedicine 2025cited by 3position: middledoi
Clinical characteristics and treatment patterns of patients with gastroenteropancreatic neuroendocrine neoplasia in Germany receiving peptide receptor radionuclide therapy: A real-world data registry-based study
Medicine 2025cited by 3position: middledoi
Imaging-derived biomarkers from 68Ga-DOTATOC PET/CT scans to predict survival of patients with neuroendocrine tumors after PRRT with 177Lu-DOTATATE
Cancer Imaging 2025cited by 3position: middledoi
Activity and Safety of Avelumab in High-Grade Neuroendocrine Tumors and Poorly Differentiated Neuroendocrine Carcinomas Progressive after Chemotherapy (AveNEC Trial)
Clinical Cancer Research 2024cited by 9position: firstdoi
Multicenter analysis on the value of standard (chemo)radiotherapy in elderly patients with locally advanced adenocarcinoma of the esophagus or gastroesophageal junction
Radiation Oncology 2024cited by 3position: middledoi
Chemoradiotherapy in geriatric patients with squamous cell carcinoma of the esophagus: Multi-center analysis on the value of standard treatment in the elderly
Frontiers in Oncology 2023cited by 18position: middledoi
1185MO Activity and safety of avelumab alone or in combination with cabozantinib in patients with advanced high grade neuroendocrine neoplasias (NEN G3) progressing after chemotherapy. The phase II, open-label, multicenter AVENEC and CABOAVENEC trials
Annals of Oncology 2023cited by 9position: lastdoi
Quantitative Analysis of Plasma Cell-Free DNA and Its DNA Integrity and Hypomethylation Status as Biomarkers for Tumor Burden and Disease Progression in Patients with Metastatic Neuroendocrine Neoplasias
Cancers 2022cited by 19position: middledoi
Second MAFA Variant Causing a Phosphorylation Defect in the Transactivation Domain and Familial Insulinomatosis
Cancers 2022cited by 12position: firstdoi
Multiple modes of cell death in neuroendocrine tumors induced by artesunate
Phytomedicine 2020cited by 24position: middledoi
PD-L1 Expression and Immune Cell Infiltration in Gastroenteropancreatic (GEP) and Non-GEP Neuroendocrine Neoplasms With High Proliferative Activity
Frontiers in Oncology 2019cited by 72position: lastdoi
Peptide Receptor Radionuclide Therapy Combined With Chemotherapy in Patients With Neuroendocrine Tumors
Clinical Nuclear Medicine 2019cited by 68position: middledoi
A phase II, open label, multicenter trial of avelumab in patients with advanced, metastatic high-grade neuroendocrine carcinomas NEC G3 (WHO 2010) progressive after first-line chemotherapy (AVENEC).
Journal of Clinical Oncology 2019cited by 51position: firstdoi
Prognostic Assessment of Non‐functioning Neuroendocrine Pancreatic Neoplasms as a Basis for Risk‐Adapted Resection Strategies
World Journal of Surgery 2019cited by 12position: middledoi
Immune Checkpoint Inhibitors in the Treatment of Patients with Neuroendocrine Neoplasia
Oncology Research and Treatment 2018cited by 86position: lastdoi
Hormone secreting gastro-entero-pancreatic neuroendocrine neoplasias (GEP-NEN): When to consider, how to diagnose?
Reviews in Endocrine and Metabolic Disorders 2017cited by 52position: firstdoi
The impact of the IGF-1 system of cancer cells on radiation response – An in vitro study
Clinical and Translational Radiation Oncology 2017cited by 23position: middledoi
Surgical Treatment of NEN of Small Bowel: A Retrospective Analysis
World Journal of Surgery 2016cited by 51position: middledoi
Impact of combined FDG-PET/CT and MRI on the detection of local recurrence and nodal metastases in thyroid cancer
Cancer Imaging 2016cited by 28position: middledoi
Interdisciplinary treatment of diabetic foot wounds in the elderly: Low risk of amputations and mortality and good chance of being mobile with good quality of life
Diabetes and Vascular Disease Research 2016cited by 13position: middledoi
Prognostic factors in stage III–IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study
Annals of Oncology 2015cited by 252position: middledoi
Surgical therapy of neuroendocrine neoplasm with hepatic metastasis: patient selection and prognosis
Langenbeck s Archives of Surgery 2015cited by 58position: middledoi
DNA Double Strand Breaks as Predictor of Efficacy of the Alpha-Particle Emitter Ac-225 and the Electron Emitter Lu-177 for Somatostatin Receptor Targeted Radiotherapy
PLoS ONE 2014cited by 137position: middledoi
Associations between Depression and Diabetes in the Community: Do Symptom Dimensions Matter? Results from the Gutenberg Health Study
PLoS ONE 2014cited by 38position: middledoi
Phenotypic Variability and Risk of Malignancy in<i>SDHC</i>-Linked Paragangliomas: Lessons From Three Unrelated Cases With an Identical Germline Mutation (p.Arg133*)
The Journal of Clinical Endocrinology & Metabolism 2014cited by 29position: lastdoi
Critical limb ischaemia is characterised by an increased production of whole blood reactive oxygen species and expression of TREM-1 on neutrophils
Atherosclerosis 2013cited by 57position: middledoi
Magnetic separation of encapsulated islet cells labeled with superparamagnetic iron oxide nano particles
Xenotransplantation 2013cited by 23position: middledoi
High incidence of extraadrenal paraganglioma in families with SDHx syndromes detected by functional imaging with [18F]fluorodihydroxyphenylalanine PET
European Journal of Nuclear Medicine and Molecular Imaging 2013cited by 18position: middledoi
The Role of Surgery in the Management of Recurrent Adrenocortical Carcinoma
The Journal of Clinical Endocrinology & Metabolism 2012cited by 154position: middledoi
Phenotypic characterisation of pro-inflammatory monocytes and dendritic cells in peripheral arterial disease
Thrombosis and Haemostasis 2012cited by 37position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Matthias M. Weber · Johannes Gutenberg University Mainz22 papers (2012–2025)Matthias Miederer · DKFZ-ZMBH Alliance11 papers (2013–2025)Thomas J. Musholt · Johannes Gutenberg University Mainz10 papers (2012–2025)Arno Schad · University Hospital and Clinics8 papers (2012–2022)Mathias Schreckenberger · Johannes Gutenberg University Mainz6 papers (2013–2025)Esther Mettler · Johannes Gutenberg University Mainz5 papers (2013–2024)Wilfried Roth · Johannes Gutenberg University Mainz4 papers (2019–2024)Felix Watzka · Johannes Gutenberg University Mainz4 papers (2012–2019)Hauke Lang · Johannes Gutenberg University Mainz4 papers (2012–2019)Karl J. Lackner · Johannes Gutenberg University Mainz4 papers (2013–2022)Anja Rinke · Phillips University3 papers (2023–2025)Simin Schadmand‐Fischer · Johannes Gutenberg University Mainz3 papers (2016–2025)Patrick Michl · University Hospital Heidelberg3 papers (2019–2024)Leonidas Apostolidis · University Hospital Heidelberg3 papers (2019–2024)Sebastian Krug · University Hospital Heidelberg3 papers (2019–2024)Martina Ferrata · Johannes Gutenberg University Mainz3 papers (2017–2019)Peter R. Galle · University of Lübeck3 papers (2019–2024)Heidi Rossmann · Johannes Gutenberg University Mainz3 papers (2013–2022)Thomas Münzel · Medical Genetics Center3 papers (2012–2014)Felix Beuschlein · Ollscoil na Gaillimhe – University of Galway2 papers (2012–2025)